InsidersTradesSigma
Track the 레이 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 레이 has logged 141 reports. Market capitalisation: €83.8bn. The latest transaction was filed on 13 July 2026 (Purchase). Among the most active insiders: 미래에셋자산운용. Every trade is accessible without an account.
137
Insider Decl.
n/a
Thresholds
€3m
40 ops.
Buy Volume
€117,409
72 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,635 of 29,057 companies
53.6
score / 100
Value68
Quality40
FCF yld11%
Earn yld3.7%
EV/EBITDA9.6x
ROE1.3%
Gross mgn47%
Net mgn2.8%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations141 total
Other
Other
Other
Other
25 of 141 declarations
About 레이
레이 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on the development and commercialization of innovative pharmaceutical products.